[1]梁凯,胡慧青,崔晨,等.甲状腺微小乳头状癌治疗策略的共识与争议[J].国际内分泌代谢杂志,2023,43(02):100-103,112.[doi:10.3760/cma.j.cn121383-20220424-04056]
　Liang Kai,Hu Huiqing,Cui Chen,et al.Consensus and controversy on treatment strategies for papillary thyroid microcarcinoma[J].International Journal of Endocrinology and Metabolism,2023,43(02):100-103,112.[doi:10.3760/cma.j.cn121383-20220424-04056]
点击复制

甲状腺微小乳头状癌治疗策略的共识与争议()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
43
期数:
2023年02期
页码:
100-103,112
栏目:
综述
出版日期:
2023-03-20

文章信息/Info

Title:
Consensus and controversy on treatment strategies for papillary thyroid microcarcinoma
作者:
梁凯; 胡慧青; 崔晨; 侯新国; 陈丽
山东大学齐鲁医院内分泌与代谢病科,山东大学内分泌代谢病研究所,山东省医药卫生内分泌与代谢病重点实验室,济南市内分泌与代谢病临床医学研究中心,济南 250012
Author(s):
Liang Kai;  Hu Huiqing;  Cui Chen;  Hou Xinguo;  Chen Li.
Department of Endocrinology and Metabolic Diseases, Qilu Hospital of Shandong University, Institute of Endocrine and Metabolic Diseases of Shandong University, Key Laboratory of Endocrine and Metabolic Diseases, Shandong Province Medicine & Health, Jinan Clinical Research Center for Endocrine and Metabolic Diseases, Jinan 250012, China
关键词:
甲状腺微小乳头状癌;  手术治疗;  积极监测;  热消融治疗
Keywords:
Papillary thyroid microcarcinoma;  Surgical treatment;  Active surveillance;  Thermal ablation
DOI:
10.3760/cma.j.cn121383-20220424-04056
摘要:
近年来,甲状腺微小乳头状癌(papillary thyroid microcarcinoma, PTMC)患病率急剧上升。PTMC的规范治疗越来越受到临床医生的关注。目前,PTMC的主要治疗策略包括手术治疗、积极监测、热消融治疗等。手术治疗是甲状腺癌的标准治疗,但PTMC手术的必要性和手术范围尚存在争议。而积极监测和热消融治疗都是基于循证医学证据的新治疗策略,尤其对低危PTMC取得了良好的治疗效果。本文就PTMC的3种治疗策略及国内外共识与争议进行综述,以期提供良好的治疗引导。
Abstract:
In recent years, the prevalence of papillary thyroid microcarcinoma(PTMC)has risen sharply. The standard treatment of PTMC has attracted more and more attention of clinicians. At present, the main treatment strategies for PTMC include surgical treatment, active surveillance, thermal ablation, etc. Surgical treatment is the standard treatment for thyroid cancer, but the necessity and scope of PTMC surgery are still controversial. Active surveillance and thermal ablation therapy are new treatment strategies based on evidence-based medicine, and have achieved good therapeutic effects especially on low-risk PTMC. This article reviews the three treatment strategies of PTMC and their domestic and international consensus and controversies, in order to provide good treatment guidance.

参考文献/References:

[1] McGuire S.World Cancer Report 2014.Geneva,Switzerland:World Health Organization,International Agency for Research on Cancer,WHO Press,2015[J].Adv Nutr,2016,7(2):418-419.DOI:10.3945/an.116.012211.
[2] Rosko AJ,Gay BL,Reyes-Gastelum D,et al.Surgeons' attitudes on total thyroidectomy vs lobectomy for management of papillary thyroid microcarcinoma[J].JAMA Otolaryngol Head Neck Surg,2021,147(7):667-669.DOI:10.1001/jamaoto.2021.0525.
[3] Lee J,Park JH,Lee CR,et al.Long-term outcomes of total thyroidectomy versus thyroid lobectomy for papillary thyroid microcarcinoma:comparative analysis after propensity score matching[J].Thyroid,2013,23(11):1408-1415.DOI:10.1089/thy.2012.0463.
[4] Welch HG,Doherty GM.Saving thyroids - overtreatment of small papillary cancers[J].N Engl J Med,2018,379(4):310-312.DOI:10.1056/NEJMp1804426.
[5] Nickel B,Tan T,Cvejic E,et al.Health-related quality of life after diagnosis and treatment of differentiated thyroid cancer and association with type of surgical treatment[J].JAMA Otolaryngol Head Neck Surg,2019,145(3):231-238.DOI:10.1001/jamaoto.2018.3870.
[6] 中国临床肿瘤学会指南工作委员会.中国临床肿瘤学会(CSCO)分化型甲状腺癌诊疗指南2021[J].肿瘤预防与治疗,2021,34(12):1164-1201.DOI:10.3969/j.issn.1674-0904.2021.12.013.
[7] 秦元,张浩.国内外指南中甲状腺癌颈淋巴结清扫手术范围及指征变迁[J].中国实用外科杂志,2020,40(6):639-643.DOI:10.19538/j.cjps.issn1005-2208.2020.06.04.
[8] Dismukes J,Fazendin J,Obiarinze R,et al.Prophylactic central neck dissection in papillary thyroid carcinoma:all risks,no reward[J].J Surg Res,2021,264:230-235.DOI:10.1016/j.jss.2021.02.035.
[9] Tuttle RM,Haugen B,Perrier ND.Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging System for Differentiated and Anaplastic Thyroid Cancer(Eighth Edition):What Changed and Why?[J].Thyroid,2017,27(6):751-756.DOI:10.1089/thy.2017.0102.
[10] Hay ID,Johnson TR,Kaggal S,et al.Papillary thyroid carcinoma(PTC)in children and adults:comparison of initial presentation and long-term postoperative outcome in 4432 patients consecutively treated at the Mayo clinic during eight decades(1936-2015)[J].World J Surg,2018,42(2):329-342.DOI:10.1007/s00268-017-4279-x.
[11] Miyauchi A.Clinical trials of active surveillance of papillary microcarcinoma of the thyroid[J].World J Surg,2016,40(3):516-522.DOI:10.1007/s00268-015-3392-y.
[12] Sugitani I,Ito Y,Takeuchi D,et al.Indications and Strategy for Active Surveillance of Adult Low-Risk Papillary Thyroid Microcarcinoma:Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma[J].Thyroid,2021,31(2):183-192.DOI:10.1089/thy.2020.0330.
[13] 中国抗癌协会甲状腺癌专业委员会(CATO).甲状腺微小乳头状癌诊断与治疗中国专家共识(2016版)[J].中国肿瘤临床,2016,43(10):405-411.DOI:10.3969/j.issn.1000-8179.2016.10.001.
[14] Tuttle RM,Zhang L,Shaha A.A clinical framework to facilitate selection of patients with differentiated thyroid cancer for active surveillance or less aggressive initial surgical management[J].Expert Rev Endocrinol Metab,2018,13(2):77-85.DOI:10.1080/17446651.2018.1449641.
[15] Sakai T,Sugitani I,Ebina A,et al.Active surveillance for T1bN0M0 papillary thyroid carcinoma[J].Thyroid,2019,29(1):59-63.DOI:10.1089/thy.2018.0462.
[16] Miyauchi A,Ito Y,Oda H.Insights into the management of papillary microcarcinoma of the thyroid[J].Thyroid,2018,28(1):23-31.DOI:10.1089/thy.2017.0227.
[17] 中国医师协会超声医师分会.甲状腺微小乳头状癌热消融诊疗指佂专家共识[J].中华医学超声杂志(电子版),2019,16(8):571-574.DOI:10.3877/cma.j.issn.1672-6448.2019.08.004.
[18] van Dijk SPJ,Coerts HI,Gunput STG,et al.Assessment of radiofrequency ablation for papillary microcarcinoma of the thyroid:a systematic review and meta-analysis[J].JAMA Otolaryngol Head Neck Surg,2022,148(4):317-325.DOI:10.1001/jamaoto.2021.4381.
[19] Bernardi S,Palermo A,Grasso RF,et al.Current status and challenges of US-guided radiofrequency ablation of thyroid nodules in the long term:a systematic review[J].Cancers(Basel),2021,13(11):2746.DOI:10.3390/cancers13112746.
[20] Ma B,Wei W,Xu W,et al.Surgical confirmation of incomplete treatment for primary papillary thyroid carcinoma by percutaneous thermal ablation:a retrospective case review and literature review[J].Thyroid,2018,28(9):1134-1142.DOI:10.1089/thy.2017.0558.
[21] Mauri G,Hegedüs L,Bandula S,et al.European Thyroid Association and Cardiovascular and Interventional Radiological Society of Europe 2021 Clinical Practice Guideline for the Use of Minimally Invasive Treatments in Malignant Thyroid Lesions[J].Eur Thyroid J,2021,10(3):185-197.DOI:10.1159/000516469.
[22] Orloff LA,Noel JE,Stack BC Jr,et al.Radiofrequency ablation and related ultrasound-guided ablation technologies for treatment of benign and malignant thyroid disease:an international multidisciplinary consensus statement of the American Head and Neck Society Endocrine Surgery Section with the Asia Pacific Society of Thyroid Surgery,Associazione Medici Endocrinologi,British Association of Endocrine and Thyroid Surgeons,European Thyroid Association,Italian Society of Endocrine Surgery Units,Korean Society of Thyroid Radiology,Latin American Thyroid Society,and Thyroid Nodules Therapies Association[J].Head Neck,2022,44(3):633-660.DOI:10.1002/hed.26960.
[23] Yan L,Luo Y,Zhang Y,et al.The clinical application of core-needle biopsy after radiofrequency ablation for low-risk papillary thyroid microcarcinoma:a large cohort of 202 patients study[J].J Cancer,2020,11(18):5257-5263.DOI:10.7150/jca.42673.

相似文献/References:

[1]陆晨雅,褚晓秋,陈国芳,等.微波消融治疗低危甲状腺微小乳头状癌的临床疗效和病理改变[J].国际内分泌代谢杂志,2021,41(03):184.[doi:10.3760/cma.j.cn121383-20210105-01009]
　Lu Chenya,Chu Xiaoqiu,Chen Guofang,et al.Clinical effects of microwave ablation in the treatment of low risk papillary thyroid microcarcinomas and related pathological changes[J].International Journal of Endocrinology and Metabolism,2021,41(02):184.[doi:10.3760/cma.j.cn121383-20210105-01009]

备注/Memo

备注/Memo:
通信作者:陈丽,Email:chenli3@email.sdu.edu.cn
更新日期/Last Update: 2023-04-15